Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (121) 121
humans (119) 119
prostate cancer (105) 105
male (104) 104
urology (79) 79
urology & nephrology (78) 78
cancer (72) 72
aged (69) 69
middle aged (67) 67
oncology (56) 56
magnetic resonance imaging (55) 55
prostatic neoplasms - pathology (52) 52
prostate (48) 48
biopsy (34) 34
surgery (29) 29
diagnosis (28) 28
prostatic neoplasms - diagnostic imaging (27) 27
care and treatment (25) 25
prostate - pathology (25) 25
metastasis (24) 24
retrospective studies (24) 24
aged, 80 and over (23) 23
female (23) 23
prospective studies (23) 23
tumors (22) 22
tomography (21) 21
adult (20) 20
medicine & public health (19) 19
patients (19) 19
radical prostatectomy (19) 19
survival (19) 19
treatment outcome (19) 19
analysis (18) 18
chemotherapy (18) 18
prostatic neoplasms - diagnosis (18) 18
animals (17) 17
computed tomography (16) 16
medical research (16) 16
metastases (16) 16
prostatic neoplasms - surgery (16) 16
research (16) 16
therapy (16) 16
image-guided biopsy - methods (15) 15
men (15) 15
positron emission (15) 15
prognosis (15) 15
bladder cancer (14) 14
abridged index medicus (13) 13
apoptosis (13) 13
carcinoma (13) 13
cell line, tumor (13) 13
complications (13) 13
expression (13) 13
health aspects (13) 13
mri (13) 13
radiology, nuclear medicine & medical imaging (13) 13
ligands (12) 12
neoplasm grading (12) 12
nuclear medicine (12) 12
predictive value of tests (12) 12
prostate - diagnostic imaging (12) 12
prostate-specific antigen (12) 12
prostatic neoplasms (12) 12
urinary bladder neoplasms - pathology (12) 12
antigens (11) 11
mice (11) 11
nuclear magnetic resonance--nmr (11) 11
radiotherapy (11) 11
risk factors (11) 11
cohort studies (10) 10
magnetic resonance imaging - methods (10) 10
medical imaging (10) 10
methods (10) 10
neoplasm staging (10) 10
outcomes (10) 10
pet/ct (10) 10
positron-emission tomography (10) 10
prostate-specific antigen - blood (10) 10
sensitivity and specificity (10) 10
time factors (10) 10
bladder (9) 9
follow-up studies (9) 9
imaging / radiology (9) 9
localization (9) 9
mice, nude (9) 9
prostatectomy (9) 9
prostatic neoplasms - therapy (9) 9
risk assessment (9) 9
system (9) 9
usage (9) 9
accuracy (8) 8
antigen (8) 8
biochemical recurrence (8) 8
cardiology (8) 8
cells (8) 8
clinical trials (8) 8
disease-free survival (8) 8
hematology, oncology and palliative medicine (8) 8
histopathology (8) 8
image-guided biopsy (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Re:.sup.225Ac-PSMA-617 for PSMA-Targeting Alpha-radiation Therapy of Patients with Metastatic Castration-resistant Prostate Cancer
by Hadaschik, Boris
European Urology, ISSN 0302-2838, 12/2016, Volume 70, Issue 6, p. 1080
Care and treatment | Radiation | Metastasis | Radiotherapy | Prostate cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Re: 225Ac-PSMA-617 for PSMA-Targeting Alpha-radiation Therapy of Patients with Metastatic Castration-resistant Prostate Cancer
by Hadaschik, Boris
European Urology, ISSN 0302-2838, 12/2016, Volume 70, Issue 6, pp. 1080 - 1081
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Re:225 Ac-PSMA-617 for PSMA-Targeting Alpha-radiation Therapy of Patients with Metastatic Castration-resistant Prostate Cancer
by Hadaschik, Boris
European Urology, ISSN 0302-2838, 2016, Volume 70, Issue 6, pp. 1080 - 1081
Urology | Alpha Particles | Prostatic Neoplasms, Castration-Resistant | Humans | Dipeptides | Male | Antigens, Surface | Glutamate Carboxypeptidase II | Heterocyclic Compounds, 1-Ring
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Re: Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial
by Hadaschik, Boris and Ost, Piet
European Urology, ISSN 0302-2838, 10/2019, Volume 76, Issue 4, pp. 538 - 539
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Re: Preliminary Results for Avelumab Plus Axitinib as First-Line Therapy in Patients with Advanced Clear-cell Renal-cell Carcinoma (JAVELIN Renal 100): An Open-label, Dose-finding and Dose-expansion, Phase 1b Trial
by Grünwald, Viktor and Hadaschik, Boris
European Urology, ISSN 0302-2838, 04/2019, Volume 75, Issue 4, pp. 697 - 698
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text 1041 BILLROTH AND BRAHMS–PERSONAL ENCOUNTER OF MEDICINE AND MUSIC
by Hadaschik, Boris
Journal of Urology, The, ISSN 0022-5347, 2011, Volume 185, Issue 4, pp. e419 - e419
Urology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Why Targeting of PSMA Is a Valuable Addition to the Management of Castration-Resistant Prostate Cancer: The Urologist’s Point of View
by Hadaschik, Boris A and Boegemann, Martin
Journal of Nuclear Medicine, ISSN 0161-5505, 08/2017, Volume 58, Issue 8, pp. 1207 - 1209
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
by Kasivisvanathan, Veeru and Rannikko, Antti S and Borghi, Marcelo and Panebianco, Valeria and Mynderse, Lance A and Vaarala, Markku H and Briganti, Alberto and Budäus, Lars and Hellawell, Giles and Hindley, Richard G and Roobol, Monique J and Eggener, Scott and Ghei, Maneesh and Villers, Arnauld and Bladou, Franck and Villeirs, Geert M and Virdi, Jaspal and Boxler, Silvan and Robert, Grégoire and Singh, Paras B and Venderink, Wulphert and Hadaschik, Boris A and Ruffion, Alain and Hu, Jim C and Margolis, Daniel and Crouzet, Sébastien and Klotz, Laurence and Taneja, Samir S and Pinto, Peter and Gill, Inderbir and Allen, Clare and Giganti, Francesco and Freeman, Alex and Morris, Stephen and Punwani, Shonit and Williams, Norman R and Brew-Graves, Chris and Deeks, Jonathan and Takwoingi, Yemisi and Emberton, Mark and Moore, Caroline M and PRECISION Study Grp Collaborators and PRECISION Study Group Collaborators and Lund University and Urological cancer, Malmö and Urologisk cancerforskning, Malmö and EpiHealth: Epidemiology for Health and eSSENCE: The e-Science Collaboration and BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation and Lunds universitet
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 19, pp. 1767 - 1777
Prostate-cancer biopsy directed at areas of MRI abnormality was compared with standard transrectal ultrasonographic biopsy for diagnostic specificity and... 
MEDICINE, GENERAL & INTERNAL | COST-EFFECTIVENESS | FUSION | ACTIVE SURVEILLANCE | MEN | MAGNETIC-RESONANCE | OUTCOMES | ULTRASOUND-GUIDED BIOPSY | Biopsy - methods | Prostatic Neoplasms - pathology | Follow-Up Studies | Risk Assessment | Humans | Middle Aged | Ultrasonography, Interventional | Male | Biopsy - adverse effects | Magnetic Resonance Imaging | Prostate - pathology | Prostate - diagnostic imaging | Intention to Treat Analysis | Prostatic Neoplasms - diagnostic imaging | Quality of Life | Surveys and Questionnaires | Aged | Quality Control | Usage | Magnetic resonance imaging | Biopsy | Men | Diagnosis | Health aspects | Prostate cancer | Medical research | Nuclear magnetic resonance--NMR | Prostate-specific antigen | Urology | Ultrasonic imaging | Hospitals | Risk assessment | Ultrasonography | Prostate | Clinical Medicine | Urologi och njurmedicin | Medical and Health Sciences | Radiologi och bildbehandling | Medicin och hälsovetenskap | Radiology, Nuclear Medicine and Medical Imaging | Klinisk medicin | Cancer and Oncology | Urology and Nephrology | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
by Smith, Matthew R and Saad, Fred and Chowdhury, Simon and Oudard, Stéphane and Hadaschik, Boris A and Graff, Julie N and Olmos, David and Mainwaring, Paul N and Lee, Ji Youl and Uemura, Hiroji and Lopez-Gitlitz, Angela and Trudel, Géralyn C and Espina, Byron M and Shu, Youyi and Park, Youn C and Rackoff, Wayne R and Yu, Margaret K and Small, Eric J and SPARTAN Investigators and Sahlgrenska akademin and Institute of Clinical Sciences and Institutionen för kliniska vetenskaper and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
The New England Journal of Medicine, ISSN 0028-4793, 04/2018, Volume 378, Issue 15, pp. 1408 - 1418
Among men with nonmetastatic prostate cancer who had a rapid PSA doubling time and were receiving androgen-deprivation therapy, the median metastasis-free... 
MEDICINE, GENERAL & INTERNAL | THERAPY | LIGANDS | BONE METASTASES | MEN | ARN-509 | ANTIGEN | Prostate-Specific Antigen | Double-Blind Method | Humans | Middle Aged | Proportional Hazards Models | Male | Prostatic Neoplasms, Castration-Resistant - drug therapy | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease Progression | Prostatic Neoplasms, Castration-Resistant - pathology | Disease-Free Survival | Thiohydantoins - adverse effects | Exanthema - chemically induced | Neoplasm Metastasis - prevention & control | Thiohydantoins - therapeutic use | Aged, 80 and over | Androgen Antagonists - therapeutic use | Aged | Androgen Antagonists - adverse effects | Prostate cancer | Care and treatment | Metastasis | Medical research | Antigens | Lymphatic system | Medical imaging | Prostate-specific antigen | Research & development--R&D | Family medical history | Hypothyroidism | Survival | Patients | Metastases | Androgens | Hospitals | Castration | Prostate | Adenocarcinoma | pathology | Androgen Antagonists | Exanthema | 80 and over | Prostatic Neoplasms | Neoplasm Metastasis | Thiohydantoins | Urologi och njurmedicin | drug therapy | chemically induced | Castration-Resistant | prevention & control | secondary | adverse effects | Urology and Nephrology | therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Characterization of colon cancer cells: A functional approach characterizing CD133 as a potential stem cell marker
by Schneider, Meike and Huber, Johannes and Hadaschik, Boris and Siegers, Gabrielle M and Fiebig, Heinz-Herbert and Schüler, Julia
BMC Cancer, ISSN 1471-2407, 03/2012, Volume 12, Issue 1, pp. 96 - 96
Background: Isolation and characterization of tumourigenic colon cancer initiating cells may help to develop novel diagnostic and therapeutic procedures.... 
Cancer stem cell like properties | Colon cancer | Stem cells | CD133 | METASTASIS | IDENTIFICATION | IN-VITRO | GENE | ONCOLOGY | COLORECTAL-CANCER | DOMAIN-CONTAINING PROTEIN-1 | DIFFERENTIATION | CD24 | TUMOR-GROWTH | EXPRESSION | Immunohistochemistry | Peptides | Humans | Middle Aged | Male | RNA, Messenger - metabolism | Colonic Neoplasms - metabolism | Antigens, CD - metabolism | Flow Cytometry | Colonic Neoplasms - immunology | Biomarkers, Tumor - metabolism | Adult | Female | Carcinoma - pathology | Carcinoma - immunology | Glycoproteins | AC133 Antigen | Receptors, CXCR4 - metabolism | Animals | Mice, Nude | Colonic Neoplasms - pathology | Cell Line, Tumor | Aged | Mice | Carcinoma - metabolism | Cellular proteins | Research | Analysis | Cancer cells
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Re: Assessment of 68 Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial
by Hadaschik, Boris and Ost, Piet
European urology, 05/2019
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Investigation of the halo-artifact in 68Ga-PSMA-11-PET/MRI
by Heußer, Thorsten and Mann, Philipp and Rank, Christopher M and Schäfer, Martin and Dimitrakopoulou-Strauss, Antonia and Schlemmer, Heinz-Peter and Hadaschik, Boris A and Kopka, Klaus and Bachert, Peter and Kachelrieß, Marc and Freitag, Martin T
PLoS ONE, ISSN 1932-6203, 08/2017, Volume 12, Issue 8, p. e0183329
Combined positron emission tomography (PET) and magnetic resonance imaging (MRI) targeting the prostate-specific membrane antigen (PSMA) with a 68Ga-labelled... 
Artifacts | Magnetic Resonance Imaging | Humans | Middle Aged | Male | Positron-Emission Tomography | Galium - chemistry | Emission analysis | Bladder | Metastasis | Health physics | Pelvis | Medical diagnosis | Image reconstruction | Computed tomography | Urinary bladder | Tomography | Medical research | Kidneys | Statistical analysis | Medical imaging | Computer simulation | Scattering | Positron emission | Patients | Readers | Physics | Abdomen | Algorithms | Magnetic resonance imaging | Scaling | Diagnostic systems | Clinical medicine | Prostate cancer | Positron emission tomography | Prostate | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image‐fusion guided transperineal prostate biopsy in patients with a previous negative biopsy
by Hansen, Nienke L and Kesch, Claudia and Barrett, Tristan and Koo, Brendan and Radtke, Jan P and Bonekamp, David and Schlemmer, Heinz‐Peter and Warren, Anne Y and Wieczorek, Kathrin and Hohenfellner, Markus and Kastner, Christof and Hadaschik, Boris
BJU International, ISSN 1464-4096, 11/2017, Volume 120, Issue 5, pp. 631 - 638
Objectives To evaluate the detection rates of targeted and systematic biopsies in magnetic resonance imaging (MRI) and ultrasound (US) image‐fusion... 
prostate biopsy | magnetic resonance imaging | prostate cancer | image fusion | transperineal biopsy | PCSM | prostate‐specific antigen density | ProstateCancer | prostate-specific antigen density | DIAGNOSIS | INTERNATIONAL-SOCIETY | MRI | GUIDELINES | ISUP CONSENSUS CONFERENCE | TRIAL | SPECIMENS | CANCER DETECTION | UROLOGY & NEPHROLOGY | VALUES | CARCINOMA | Predictive Value of Tests | Prostatic Neoplasms - pathology | Prospective Studies | Humans | Middle Aged | Magnetic Resonance Imaging, Interventional - statistics & numerical data | Ultrasonography, Interventional - statistics & numerical data | Male | Prostatic Neoplasms - epidemiology | Image-Guided Biopsy - statistics & numerical data | Prostate - pathology | Prostate - diagnostic imaging | Prostatic Neoplasms - diagnostic imaging | Aged | Medicine, Experimental | Medical research | Care and treatment | Biopsy | Prostate cancer | Prostate | Ultrasonic imaging | Nuclear magnetic resonance--NMR | Magnetic resonance imaging | Benign | Ultrasound
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Evaluation of an automated analysis tool for prostate cancer prediction using multiparametric magnetic resonance imaging
by Roethke, Matthias C and Kuru, Timur H and Mueller-Wolf, Maya B and Agterhuis, Erik and Edler, Christopher and Hohenfellner, Markus and Schlemmer, Heinz-Peter and Hadaschik, Boris A
PLoS ONE, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, p. e0159803
Objective To evaluate the diagnostic performance of an automated analysis tool for the assessment of prostate cancer based on multiparametric magnetic... 
SYSTEM | DIAGNOSIS | FUSION | MRI | MULTIDISCIPLINARY SCIENCES | SOCIETY | ULTRASOUND-GUIDED BIOPSY | ACCURACY | Prostatic Neoplasms - pathology | Reproducibility of Results | Prognosis | Humans | Image-Guided Biopsy - methods | Middle Aged | Magnetic Resonance Imaging - methods | Male | Image Processing, Computer-Assisted - methods | Algorithms | Sensitivity and Specificity | Prostatic Neoplasms - diagnostic imaging | ROC Curve | Aged | Retrospective Studies | Software | Usage | Diagnosis | Magnetic resonance imaging | Prostate cancer | Medical research | Automation | Sensitivity analysis | Nuclear magnetic resonance--NMR | Computer simulation | Tools | Malignancy | Multivariate analysis | Medical diagnosis | Patients | Urology | Readers | Studies | Histopathology | Maps | Diagnostic software | Resonance | Diagnostic systems | Prostate | Methods | Cancer | NMR | Nuclear magnetic resonance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Editorial Comment to Assessing clinically significant prostate cancer: Diagnostic properties of multiparametric magnetic resonance imaging compared to three‐dimensional transperineal template mapping histopathology
by Kesch, Claudia and Hadaschik, Boris A and Radtke, Jan P
International Journal of Urology, ISSN 0919-8172, 02/2017, Volume 24, Issue 2, pp. 143 - 144
Magnetic resonance imaging | Comparative analysis | Prostate cancer | Histochemistry | Mapping | Prostate
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Therapy assessment in prostate cancer using choline and PSMA PET/CT
by Ceci, Francesco and Herrmann, Ken and Hadaschik, Boris and Castellucci, Paolo and Fanti, Stefano
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 08/2017, Volume 44, Issue Suppl 1, pp. 78 - 83
While PET with non-FDG tracers (mainly choline and Ga-PSMA) has commonly been used for restaging in men with biochemically recurrent prostate cancer, as well... 
mCRPC | Pet/Ct | PSMA | Prostate cancer | Choline | Therapy assessment | PREDICTS | RESPONSE ASSESSMENT | BIOCHEMICAL FAILURE | F-18-FLUOROCHOLINE PET/CT | ANDROGEN-DEPRIVATION | C-11-CHOLINE PET/CT | INCREASED SURVIVAL | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ESTRO-SIOG GUIDELINES | ENZALUTAMIDE | ABIRATERONE | Radioactive Tracers | Glutamate Carboxypeptidase II - metabolism | Humans | Antigens, Surface - metabolism | Prostatic Neoplasms - diagnostic imaging | Male | Positron Emission Tomography Computed Tomography - methods | Prostatic Neoplasms - therapy | Therapy | Positron emission | Patients | Cancer therapies | Metastases | Computed tomography | Medical prognosis | Men | Tomography | Prostate | Cancer | Tracers
Journal Article
Details down arrow
17. Full Text The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
by Afshar-Oromieh, Ali and Avtzi, Eleni and Giesel, Frederik L and Holland-Letz, Tim and Linhart, Heinz G and Eder, Matthias and Eisenhut, Michael and Boxler, Silvan and Hadaschik, Boris A and Kratochwil, Clemens and Weichert, Wilko and Kopka, Klaus and Debus, Jürgen and Haberkorn, Uwe
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 2/2015, Volume 42, Issue 2, pp. 197 - 209
Since the introduction of positron emission tomography (PET) imaging with 68Ga-PSMA-HBED-CC (=68Ga-DKFZ-PSMA-11), this method has been regarded as a... 
PSMA | Medicine & Public Health | FECH | Orthopedics | PET/CT | Oncology | Nuclear Medicine | Imaging / Radiology | Cardiology | FMCH | Prostate cancer | Positron emission tomography | Original | PET
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy‐naïve men with suspicion of prostate cancer
by Hansen, Nienke L and Barrett, Tristan and Kesch, Claudia and Pepdjonovic, Lana and Bonekamp, David and O'Sullivan, Richard and Distler, Florian and Warren, Anne and Samel, Christina and Hadaschik, Boris and Grummet, Jeremy and Kastner, Christof
BJU International, ISSN 1464-4096, 07/2018, Volume 122, Issue 1, pp. 40 - 49
Objectives To analyse the detection rates of primary magnetic resonance imaging (MRI)‐fusion transperineal prostate biopsy using combined targeted and... 
MRI‐TRUS fusion | prostate biopsy | magnetic resonance imaging | cognitive fusion | transperineal | PCSM, #ProstateCancer | MRI-TRUS fusion | DIAGNOSIS | TARGETED BIOPSY | REPEAT BIOPSY | FUSION | MRI | GUIDELINES | PCSM | RISK | HISTOPATHOLOGY | LESIONS | ULTRASOUND-GUIDED BIOPSY | UROLOGY & NEPHROLOGY | ProstateCancer | Prostate - pathology | Prostatic Neoplasms - pathology | Neoplasm Grading | Prospective Studies | Early Detection of Cancer | Humans | Image-Guided Biopsy - methods | Middle Aged | Sensitivity and Specificity | Magnetic Resonance Imaging, Interventional - methods | Male | Aged | Nuclear magnetic resonance--NMR | Magnetic resonance imaging | Biopsy | Cognitive ability | Population studies | Prostate | Prostate cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights